ArticleStem cells translational medicine2026
A selection model for umbilical cord blood units with high isolation yield of total nucleated and CD34+ cells.
Article in Stem cells translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCord blood is an important hematopoietic stem cell source for treating over 80 FDA-approved diseases, driving demand for HSC-containing-umbilical cord blood (UCB) unit cryopreservation for future use. Total nucleated cell (TNC) and CD34+ cell amounts are key determinants of transplant success. Predicting processing outcomes is clinically valuable, particularly for public stem cell banks where storing high-quality UCB units is a priority. This study aimed to establish selection models for UCB units with high isolation yields of these critical cellular determinants.
methodsWe first performed univariate analysis and multiple linear regression on 3338 UCB units processed at MekoStem Stem Cell Bank (Vietnam) from 2019 to 2023 to explore correlations between potential variables (maternal age, mode of delivery, baby blood type, birth weight, gestational age, infant sex, blood volume, procurement time, and time to processing after collection) and TNC and CD34+ cell counts. Subsequently, Bayesian Model Averaging and exhaustive search were applied to develop predictive models. The developed models were then validated using a dataset of 660 UCB units processed in 2024.
resultsResults identified an optimal selection model incorporating birth weight, delivery mode, blood volume, and gestational age for predicting high isolation yields of both TNC and CD34+ cells. Reference values for these variables were birth weight >3200 g, vaginal delivery mode, blood volume >79.22 mL, and gestational age >39 weeks or ≤39 weeks for TNC or CD34+ cell models, respectively.
conclusionsThe models proposed in this study demonstrated robust predictive performance in external validation and can be applied to any type of stem cell bank.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.